Your browser doesn't support javascript.
loading
Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients.
Ras-Jiménez, Maria Del Mar; Ramos-Polo, Raúl; Francesch Manzano, Josep; Corbella Santano, Miriam; Morillas Climent, Herminio; Jose-Bazán, Núria; Jiménez-Marrero, Santiago; Garcimartin Cerezo, Paloma; Yun Viladomat, Sergi; Moliner Borja, Pedro; Torres Cardús, Blanca; Verdú-Rotellar, José Maria; Diez-López, Carles; González-Costello, José; García-Romero, Elena; de Frutos Seminario, Fernando; Triguero-Llonch, Laura; Enjuanes Grau, Cristina; Tajes Orduña, Marta; Comin-Colet, Josep.
Afiliación
  • Ras-Jiménez MDM; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Ramos-Polo R; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Francesch Manzano J; Department of Internal Medicine, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Corbella Santano M; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Morillas Climent H; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Jose-Bazán N; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Jiménez-Marrero S; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Garcimartin Cerezo P; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Yun Viladomat S; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • Moliner Borja P; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Torres Cardús B; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Verdú-Rotellar JM; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • Diez-López C; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Spain.
  • González-Costello J; Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • García-Romero E; Cardiology Department, Bellvitge University Hospital, 08907 L'Hospitalet de Llobregat, Spain.
  • de Frutos Seminario F; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
  • Triguero-Llonch L; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
  • Enjuanes Grau C; Advanced Practice Nurses, Hospital del Mar, Parc de Salut Mar, 08003 Barcelona, Spain.
  • Tajes Orduña M; Biomedical Research in Heart Diseases, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
  • Comin-Colet J; Escuela Superior de Enfermería del Mar, Parc de Salut Mar, 08003 Barcelona, Spain.
J Pers Med ; 13(8)2023 Aug 21.
Article en En | MEDLINE | ID: mdl-37623532

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article